Financial Performance and Subsidiaries Revenue slide image

Financial Performance and Subsidiaries Revenue

NATCO PHARMA LIMITED INVESTOR PRESENTATION Quarter I ending June 30 FY 2023-24 NATCO 1
View entire presentation